WallStreetZenWallStreetZen

NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for CPRX

Based on 5 analysts offering 12 month price targets for Catalyst Pharmaceuticals Inc.
Min Forecast
$23.00+44.93%
Avg Forecast
$27.80+75.17%
Max Forecast
$34.00+114.24%

Should I buy or sell CPRX stock?

Based on 5 analysts offering ratings for Catalyst Pharmaceuticals Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
2 analysts 40%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CPRX stock forecasts and price targets.

CPRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-10
lockedlocked$00.00+00.00%2024-03-27
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2024-03-07

1 of 1

Forecast return on equity

Is CPRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.8%

Forecast return on assets

Is CPRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CPRX revenue forecast

What is CPRX's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$461.5M+12.19%
Avg 2 year Forecast
$537.1M+30.57%
Avg 3 year Forecast
$630.3M+53.23%
CPRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CPRX earnings growth forecast

How is CPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
20.89%
Industry
8.86%
Market
18.04%
CPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
CPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
CPRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

CPRX revenue growth forecast

How is CPRX forecast to perform vs Biotechnology companies and vs the US market?
Company
15.07%
Industry
35.36%
Market
10.44%
CPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CPRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CPRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CPRX$15.87$27.80+75.17%Strong Buy
FUSN$21.48$20.25-5.73%Hold
RCKT$21.42$54.33+153.66%Strong Buy
GLPG$27.27$34.50+26.51%Sell
INBX$34.14N/AN/A

Catalyst Pharmaceuticals Stock Forecast FAQ

Is Catalyst Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: CPRX) stock is to Strong Buy CPRX stock.

Out of 5 analysts, 3 (60%) are recommending CPRX as a Strong Buy, 2 (40%) are recommending CPRX as a Buy, 0 (0%) are recommending CPRX as a Hold, 0 (0%) are recommending CPRX as a Sell, and 0 (0%) are recommending CPRX as a Strong Sell.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.

What is CPRX's revenue growth forecast for 2024-2026?

(NASDAQ: CPRX) Catalyst Pharmaceuticals's forecast annual revenue growth rate of 15.07% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.36%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.44%.

Catalyst Pharmaceuticals's revenue in 2024 is $411,347,000.On average, 5 Wall Street analysts forecast CPRX's revenue for 2024 to be $54,510,817,649, with the lowest CPRX revenue forecast at $54,115,604,595, and the highest CPRX revenue forecast at $55,041,626,814. On average, 5 Wall Street analysts forecast CPRX's revenue for 2025 to be $63,438,191,550, with the lowest CPRX revenue forecast at $61,963,170,443, and the highest CPRX revenue forecast at $65,508,985,115.

In 2026, CPRX is forecast to generate $74,450,296,595 in revenue, with the lowest revenue forecast at $67,829,946,417 and the highest revenue forecast at $81,912,807,287.

What is CPRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CPRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CPRX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year CPRX price target, the average CPRX price target is $27.80, with the highest CPRX stock price forecast at $34.00 and the lowest CPRX stock price forecast at $23.00.

On average, Wall Street analysts predict that Catalyst Pharmaceuticals's share price could reach $27.80 by May 10, 2025. The average Catalyst Pharmaceuticals stock price prediction forecasts a potential upside of 75.17% from the current CPRX share price of $15.87.

What is CPRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CPRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.